Proton Craniospinal Irradiation with Immunotherapy in Two Patients with Leptomeningeal Disease from Melanoma.
Autorzy:
Sener U; Department of Neurology, Mayo Clinic, Rochester, MN, USA.; Department of Oncology, Mayo Clinic, Rochester, MN, USA. Webb M; Department of Oncology, Mayo Clinic, Rochester, MN, USA. Breen WG; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA. Neth BJ; Department of Neurology, Mayo Clinic, Rochester, MN, USA. Laack NN; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA. Routman D; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA. Brown PD; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA. Mahajan A; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA. Frechette K; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA. DudekAZ; Department of Oncology, Mayo Clinic, Rochester, MN, USA. Markovic SN; Department of Oncology, Mayo Clinic, Rochester, MN, USA. Block MS; Department of Oncology, Mayo Clinic, Rochester, MN, USA. McWilliams RR; Department of Oncology, Mayo Clinic, Rochester, MN, USA. Dimou A; Department of Oncology, Mayo Clinic, Rochester, MN, USA. Kottschade LA; Department of Oncology, Mayo Clinic, Rochester, MN, USA. Montane HN; Department of Oncology, Mayo Clinic, Rochester, MN, USA. Kizilbash SH; Department of Oncology, Mayo Clinic, Rochester, MN, USA. Campian JL; Department of Oncology, Mayo Clinic, Rochester, MN, USA.
MET gene amplification is a mechanism of resistance to entrectinib in ROS1+ NSCLC.
Autorzy:
Tyler LC; Department of Medicine-Division of Medical Oncology, University of Colorado-Anschutz Medical Campus, Aurora, Colorado, USA. Le AT; Department of Medicine-Division of Medical Oncology, University of Colorado-Anschutz Medical Campus, Aurora, Colorado, USA. Chen N; Department of Medicine-Division of Medical Oncology, University of Colorado-Anschutz Medical Campus, Aurora, Colorado, USA. Nijmeh H; Department of Pathology, University of Colorado-Anschutz Medical Campus, Aurora, Colorado, USA. Bao L; Department of Pathology, University of Colorado-Anschutz Medical Campus, Aurora, Colorado, USA. Wilson TR; Genentech, Inc., South San Francisco, California, USA. Chen D; Genentech, Inc., South San Francisco, California, USA. Simmons B; Genentech, Inc., South San Francisco, California, USA. Turner KM; Boundless Bio, Inc., San Diego, California, USA. Perusse D; Boundless Bio, Inc., San Diego, California, USA. Kasibhatla S; Boundless Bio, Inc., San Diego, California, USA. Christiansen J; Boundless Bio, Inc., San Diego, California, USA. DudekAZ; HealthPartners Cancer Center at Regions Hospital, St. Paul, Minnesota, USA.; Department of Medicine-Division of Hematology, Oncology, and Transplantation University of Minnesota, Minneapolis, Minnesota, USA. Doebele RC; Department of Medicine-Division of Medical Oncology, University of Colorado-Anschutz Medical Campus, Aurora, Colorado, USA.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2022 Nov; Vol. 13 (21), pp. 3032-3041. Date of Electronic Publication: 2022 Sep 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Markers of endothelial glycocalyx dysfunction in Clarkson disease.
Autorzy:
Xie Z; Lung and Vascular Inflammation Section, Laboratory of Allergic Diseases, National, Institute of Allergy and Infectious Diseases/National Institutes of Health, (NIAID/NIH), 10 Center Drive, Room 11N238A, Bethesda, MD, 20892, USA. Børset M; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Immunology and Transfusion Medicine, St. Olav's University, Hospital, Trondheim, Norway. Svéen K; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway. Bøe OW; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway. Chan EC; Lung and Vascular Inflammation Section, Laboratory of Allergic Diseases, National, Institute of Allergy and Infectious Diseases/National Institutes of Health, (NIAID/NIH), 10 Center Drive, Room 11N238A, Bethesda, MD, 20892, USA. Lack JB; NIAID Collaborative Bioinformatics Resource, NIAID/NIH, Health, Bethesda, MD, 20892, USA. Hornick KM; NIAID Collaborative Bioinformatics Resource, NIAID/NIH, Health, Bethesda, MD, 20892, USA. Verlicchi F; Transfusion Medicine Faenza-Lugo, Transfusion Service Ravenna, Romagna Health Unit, Ravenna, Italy. Eisch AR; Lung and Vascular Inflammation Section, Laboratory of Allergic Diseases, National, Institute of Allergy and Infectious Diseases/National Institutes of Health, (NIAID/NIH), 10 Center Drive, Room 11N238A, Bethesda, MD, 20892, USA. Melchio R; Department of Internal Medicine, Santa Croce E Carle' Hospital, Via Michele Coppino 26, Cuneo, Italy. DudekAZ; HealthPartners Neuroscience Center, St. Paul, MN, USA. Druey KM; Lung and Vascular Inflammation Section, Laboratory of Allergic Diseases, National, Institute of Allergy and Infectious Diseases/National Institutes of Health, (NIAID/NIH), 10 Center Drive, Room 11N238A, Bethesda, MD, 20892, USA. .
The Role of Forkhead Box Protein M1 in Breast Cancer Progression and Resistance to Therapy.
Autorzy:
Saba R; Presence Saint Joseph Hospital, 2900 North Lakeshore Drive, Chicago, IL 60657, USA. Alsayed A; University of Illinois Hospital and Health Sciences System, UI Cancer Center, Medical Center Administration Building (M/C 700), 914 South Wood Street, Chicago, IL 60612, USA. Zacny JP; University of Illinois Hospital and Health Sciences System, UI Cancer Center, Medical Center Administration Building (M/C 700), 914 South Wood Street, Chicago, IL 60612, USA. DudekAZ; University of Illinois Hospital and Health Sciences System, UI Cancer Center, Medical Center Administration Building (M/C 700), 914 South Wood Street, Chicago, IL 60612, USA.
Endothelial Expression of Endothelin Receptor A in the Systemic Capillary Leak Syndrome.
Autorzy:
Sek AC; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America. Xie Z; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America. Terai K; Division of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, United States of America. Long LM; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America. Nelson C; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America. DudekAZ; Division of Hematology/Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, United States of America. Druey KM; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2015 Jul 15; Vol. 10 (7), pp. e0133266. Date of Electronic Publication: 2015 Jul 15 (Print Publication: 2015).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
SLC28A3 genotype and gemcitabine rate of infusion affect dFdCTP metabolite disposition in patients with solid tumours.
Autorzy:
Khatri A; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55414, USA. Williams BW; 1] Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55414, USA [2] Clinical Pharmacology Shared Resource of Masonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN 55414, USA. Fisher J; 1] Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55414, USA [2] Clinical Pharmacology Shared Resource of Masonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN 55414, USA. Brundage RC; Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55414, USA. Gurvich VJ; 1] Department of Medicinal Chemistry, College of Pharmacy, University of Minnesota, Minneapolis, MN 55414, USA [2] Institute for Therapeutics Discovery and Development, College of Pharmacy, University of Minnesota, Minneapolis, MN 55414, USA [3] Masonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA. Lis LG; Institute for Therapeutics Discovery and Development, College of Pharmacy, University of Minnesota, Minneapolis, MN 55414, USA. Skubitz KM; 1] Masonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA [2] Department of Medicine, School of Medicine, University of Minnesota, Minneapolis, MN 55455, USA. DudekAZ; 1] Masonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA [2] Department of Medicine, School of Medicine, University of Minnesota, Minneapolis, MN 55455, USA. Greeno EW; 1] Masonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA [2] Department of Medicine, School of Medicine, University of Minnesota, Minneapolis, MN 55455, USA. Kratzke RA; 1] Masonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA [2] Department of Medicine, School of Medicine, University of Minnesota, Minneapolis, MN 55455, USA. Lamba JK; 1] Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55414, USA [2] Masonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA [3] PUMA-Institute of Personalized Medicine, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA. Kirstein MN; 1] Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, MN 55414, USA [2] Clinical Pharmacology Shared Resource of Masonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN 55414, USA [3] Masonic Comprehensive Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA [4] PUMA-Institute of Personalized Medicine, College of Pharmacy, University of Minnesota, Minneapolis, MN 55455, USA.
Pokaż więcej
Źródło:
British journal of cancer [Br J Cancer] 2014 Jan 21; Vol. 110 (2), pp. 304-12. Date of Electronic Publication: 2013 Dec 03.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Alkylating chemotherapy may exert a uniquely deleterious effect upon neo-antigen-targeting anticancer vaccination.
Autorzy:
Litterman AJ; Masonic Cancer Center; University of Minnesota; Minneapolis; MN USA ; Brain Tumor Program; University of Minnesota; Minneapolis, MN USA ; Department of Pediatrics; University of Minnesota; Minneapolis, MN USA. DudekAZ Largaespada DA
Pokaż więcej
Źródło:
Oncoimmunology [Oncoimmunology] 2013 Oct 01; Vol. 2 (10), pp. e26294. Date of Electronic Publication: 2013 Oct 15.
DudekAZ; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA. Gupta K Ramakrishnan S Mukhopadhyay D
Pokaż więcej
Źródło:
Journal of oncology [J Oncol] 2012; Vol. 2012, pp. 857383. Date of Electronic Publication: 2012 Aug 02.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
